全球一半的食管癌在中国,这3个吃饭习惯还不改?那你真会玩自己

2021-12-22 华夏影像诊断中心 网络

全球一半的食管癌在中国

本文授权转载自微信公众号腾讯医典(ID:Dr_TXyidian)

 

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1437686, encodeId=4683143e6864b, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 24 00:37:16 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083469, encodeId=930a1083469a5, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ef82083040, createdName=1391f297e2m, createdTime=Thu Dec 23 09:29:38 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083403, encodeId=b238108340354, content=很好的科普, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e66089809, createdName=letiankongsci, createdTime=Thu Dec 23 03:30:30 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-24 zhouqu_8

    #食管#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1437686, encodeId=4683143e6864b, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 24 00:37:16 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083469, encodeId=930a1083469a5, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ef82083040, createdName=1391f297e2m, createdTime=Thu Dec 23 09:29:38 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083403, encodeId=b238108340354, content=很好的科普, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e66089809, createdName=letiankongsci, createdTime=Thu Dec 23 03:30:30 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-23 1391f297e2m

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1437686, encodeId=4683143e6864b, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101059, encryptionId=0e311010591a, topicName=食管)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Dec 24 00:37:16 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083469, encodeId=930a1083469a5, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ef82083040, createdName=1391f297e2m, createdTime=Thu Dec 23 09:29:38 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083403, encodeId=b238108340354, content=很好的科普, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e66089809, createdName=letiankongsci, createdTime=Thu Dec 23 03:30:30 CST 2021, time=2021-12-23, status=1, ipAttribution=)]
    2021-12-23 letiankongsci

    很好的科普

    0

相关威廉亚洲官网

Gastroenterology:颠覆!T1bN0M期食管鳞癌患者采用放化疗治疗的效果不劣于手术!

对于 T1bN0M0 期 ESCC 患者,联合放化疗的效果不劣于手术,可考虑作为这类患者的治疗方案

君实生物特瑞普利单抗治疗食管癌获得美国FDA孤儿药资格认定

君实生物自主研发的抗PD-1单抗药物特瑞普利单抗用于治疗食管癌(EC)获得美国食品药品监督管理局(FDA)授予的孤儿药资格认定(Orphan-drug Designation)。

许树长:3天入门实战训练营——食管疾病的内镜诊治

许树长:3天入门实战训练营——食管疾病的内镜诊治

ESMO 2021:特瑞普利单抗一线治疗食管癌的Ⅲ期临床研究结果公布,OS高达17个月

2021年9月16日至21日,2021年欧洲肿瘤内科学会(ESMO)年会采用线上会议的方式举行。作为全球最具影响力的肿瘤学术平台之一,ESMO年会每年都会汇聚全球肿瘤专业人士,共同分享肿瘤领域的前沿研

JAMA |我国学者:卡瑞丽珠单抗降低晚期食管癌患者3成生存率、4成无进展生存!

在晚期或转移性食管鳞状细胞癌患者中,在化疗的基础上加用卡瑞丽珠可显著改善总生存期和无进展生存期。

中国已成癌症大国!肺癌死亡率飙升4倍,男性高于女性​

此次2020年的《全球癌症统计报告》 共涵盖全球185个国家、36种癌症。其主要内容包括6大部分:全球癌症分布、主要致癌因素、癌症的病理过程、社会因素对于癌症预防的影响、常见癌症的预防策略及其理论基础